management problems rife in bio companies, purely because...

management problems rife in bio companies, purely because usually the scientist or professor gets it on the road, need R & D funds to help, no money for financial experts to guide them...............takes 10 years on average to get it to market, only after then do they get the financial guru's needed to steer the ship.........if they can hold out and not sell to the pharma sharks in the mean time...........happens in other companies too..........not just the bio's,
and the offer is a one for two at .03, glad its not one for one...........I am topping up, cause I think they are now getting the act together.....finally, oh and some one might take it over anyway
cheers